Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing.
Publication
, Journal Article
Colón-Emeric, CS
Published in: JAMA
December 27, 2006
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
December 27, 2006
Volume
296
Issue
24
Start / End Page
2968 / 2969
Location
United States
Related Subject Headings
- Osteoporosis, Postmenopausal
- Humans
- General & Internal Medicine
- Fractures, Bone
- Female
- Bone Density Conservation Agents
- Bone Density
- Alendronate
- Aged
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Colón-Emeric, C. S. (2006). Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing. JAMA, 296(24), 2968–2969. https://doi.org/10.1001/jama.296.24.2968
Colón-Emeric, Cathleen S. “Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing.” JAMA 296, no. 24 (December 27, 2006): 2968–69. https://doi.org/10.1001/jama.296.24.2968.
Colón-Emeric CS. Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing. JAMA. 2006 Dec 27;296(24):2968–9.
Colón-Emeric, Cathleen S. “Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing.” JAMA, vol. 296, no. 24, Dec. 2006, pp. 2968–69. Pubmed, doi:10.1001/jama.296.24.2968.
Colón-Emeric CS. Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing. JAMA. 2006 Dec 27;296(24):2968–2969.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
December 27, 2006
Volume
296
Issue
24
Start / End Page
2968 / 2969
Location
United States
Related Subject Headings
- Osteoporosis, Postmenopausal
- Humans
- General & Internal Medicine
- Fractures, Bone
- Female
- Bone Density Conservation Agents
- Bone Density
- Alendronate
- Aged
- 42 Health sciences